newsfilter
← Latest News
Business Wire·

Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines,